{"id":"https://openalex.org/W4417035355","doi":"https://doi.org/10.1056/nejmc2515117","title":"Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes","display_name":"Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes","alternate_titles":[],"publication_year":2025,"publication_date":"2025-12-03","ids":{"openalex":"https://openalex.org/W4417035355","doi":"https://doi.org/10.1056/nejmc2515117","pmid":"https://pubmed.ncbi.nlm.nih.gov/41337725"},"language":"en","primary_location":{"id":"doi:10.1056/nejmc2515117","doi":"https://doi.org/10.1056/nejmc2515117","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmc2515117","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4417035355"],"child_works_count":0,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Julio Rosenstock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio Rosenstock","raw_affiliation_strings":["Velocity Clinical Research Center at Medical City Dallas, Dallas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Velocity Clinical Research Center at Medical City Dallas, Dallas","institution_ids":["https://openalex.org/I2800474951"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Cox","raw_affiliation_strings":["Eli Lilly, Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024803356","display_name":"Max Denning","orcid":"https://orcid.org/0000-0001-6215-6885","observed_orcids":["https://orcid.org/0000-0001-6215-6885"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Max Denning","raw_affiliation_strings":["Eli Lilly, Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"393","issue":"22","first_page":"2276","last_page":"2279"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orforglipron","display_name":"orforglipron","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9279999732971191},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8759999871253967},{"id":"https://openalex.org/keywords/early-type-2-diabetes","display_name":"early type 2 diabetes","score":0.7239999771118164},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.6290000081062317},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.7609999775886536},{"id":"https://openalex.org/keywords/beta-arrestin","display_name":"beta-arrestin","score":0.7570000290870667},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.9869999885559082},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9950000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7465999722480774},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6622999906539917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5289999842643738},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4609000086784363},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4350000023841858},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.41510000824928284},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2921000123023987},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.2892000079154968},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.24639999866485596},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.218299999833107}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1056/nejmc2515117","doi":"https://doi.org/10.1056/nejmc2515117","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmc2515117","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:41337725","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41337725","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"},{"id":"pmid:41337726","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41337726","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"},{"id":"pmid:41337727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41337727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"},{"id":"pmid:41337728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41337728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2306319461","https://openalex.org/W2574032118","https://openalex.org/W2754041380","https://openalex.org/W2773969925","https://openalex.org/W4381716537","https://openalex.org/W4388592674","https://openalex.org/W4396691213","https://openalex.org/W4398781461","https://openalex.org/W4408960945","https://openalex.org/W4409963211","https://openalex.org/W4411506639","https://openalex.org/W4413117127"],"related_works":["https://openalex.org/W4414946755","https://openalex.org/W7126191026","https://openalex.org/W4417350225","https://openalex.org/W7162958217","https://openalex.org/W6949606576","https://openalex.org/W7165173781","https://openalex.org/W7160442141","https://openalex.org/W7203607052","https://openalex.org/W7204592113","https://openalex.org/W4381597870"],"abstract_inverted_index":{"To":[0],"the":[1,6,19,28,66,89],"Editor:":[2],"The":[3],"results":[4],"of":[5,22,30],"ACHIEVE-1":[7],"trial,":[8],"reported":[9],"by":[10],"Rosenstock":[11],"et":[12],"al.":[13],"(Sept.":[14],"18":[15],"issue),":[16],"1":[17],"highlight":[18],"potential":[20],"benefits":[21],"orforglipron.":[23],"This":[24],"small-molecule":[25],"drug":[26],"offers":[27],"convenience":[29],"oral":[31],"administration":[32],"without":[33,42],"injections,":[34],"which":[35,71],"may":[36],"enhance":[37],"patient":[38],"adherence.":[39],"Its":[40],"use":[41],"dietary":[43],"restrictions":[44],"also":[45],"improves":[46],"practicality.":[47],"Pharmacologically,":[48],"it":[49],"acts":[50],"as":[51,95,97],"a":[52],"partial":[53],"agonist":[54],"that":[55],"promotes":[56],"cyclic":[57],"AMP":[58],"signaling":[59],"more":[60],"strongly":[61],"than":[62],"\u03b2-arrestin":[63],"recruitment":[64],"at":[65],"glucagon-like":[67],"peptide-1":[68],"(GLP-1)":[69],"receptor,":[70],"potentially":[72],"reduces":[73],"receptor":[74],"desensitization,":[75],"although":[76],"its":[77],"clinical":[78,84],"relevance":[79],"requires":[80],"further":[81],"study.":[82],"Current":[83],"data":[85],"are":[86],"mainly":[87],"from":[88],"ACHIEVE":[90],"trials,":[91],"and":[92],"long-term":[93],"safety,":[94],"well":[96],"cardiovascular":[98],"risk":[99],"reduction":[100],".":[101,102,103]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4417035355","counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-12-04T00:00:00"}
